These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 30772752

  • 1. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.
    Li J, Wang Y, Xu X, Cao W, Shen Z, Wang N, Leng J, Zou N, Shang E, Zhu Z, Guo J, Duan J.
    Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752
    [Abstract] [Full Text] [Related]

  • 2. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
    Brettschneider F, Tölle M, von der Giet M, Passlick-Deetjen J, Steppan S, Peter M, Jankowski V, Krause A, Kühne S, Zidek W, Jankowski J.
    Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
    [Abstract] [Full Text] [Related]

  • 3. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
    Shi Y, Wang Y, Ma S, Liu T, Tian H, Zhu Q, Wang W, Li Y, Ding F.
    Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
    Yamamoto S, Sato M, Sato Y, Wakamatsu T, Takahashi Y, Iguchi A, Omori K, Suzuki Y, Ei I, Kaneko Y, Goto S, Kazama JJ, Gejyo F, Narita I.
    Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
    [Abstract] [Full Text] [Related]

  • 6. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
    Madero M, Cano KB, Campos I, Tao X, Maheshwari V, Brown J, Cornejo B, Handelman G, Thijssen S, Kotanko P.
    Clin J Am Soc Nephrol; 2019 Mar 07; 14(3):394-402. PubMed ID: 30755453
    [Abstract] [Full Text] [Related]

  • 7. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
    Böhringer F, Jankowski V, Gajjala PR, Zidek W, Jankowski J.
    ASAIO J; 2015 Mar 07; 61(1):55-60. PubMed ID: 25419832
    [Abstract] [Full Text] [Related]

  • 8. Improved dialytic removal of protein-bound uremic toxins by intravenous lipid emulsion in chronic kidney disease rats.
    Shi Y, Zhang Y, Tian H, Wang Y, Shen Y, Zhu Q, Ding F.
    Nephrol Dial Transplant; 2019 Nov 01; 34(11):1842-1852. PubMed ID: 31071223
    [Abstract] [Full Text] [Related]

  • 9. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
    Ito S, Yoshida M.
    Toxins (Basel); 2014 Feb 20; 6(2):665-78. PubMed ID: 24561478
    [Abstract] [Full Text] [Related]

  • 10. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC, Tomino Y, Lu KC.
    Toxins (Basel); 2018 Sep 11; 10(9):. PubMed ID: 30208594
    [Abstract] [Full Text] [Related]

  • 11. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
    Sato E, Saigusa D, Mishima E, Uchida T, Miura D, Morikawa-Ichinose T, Kisu K, Sekimoto A, Saito R, Oe Y, Matsumoto Y, Tomioka Y, Mori T, Takahashi N, Sato H, Abe T, Niwa T, Ito S.
    Toxins (Basel); 2017 Dec 28; 10(1):. PubMed ID: 29283413
    [Abstract] [Full Text] [Related]

  • 12. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
    Rossi M, Campbell KL, Johnson DW, Stanton T, Vesey DA, Coombes JS, Weston KS, Hawley CM, McWhinney BC, Ungerer JP, Isbel N.
    Arch Med Res; 2014 May 28; 45(4):309-17. PubMed ID: 24751327
    [Abstract] [Full Text] [Related]

  • 13. Protein-bound uremic toxins - biological effects and impact on morbidity in patients with chronic kidney disease.
    Gomółka M, Niemczyk S.
    Przegl Lek; 2017 May 28; 74(3):110-4. PubMed ID: 29694770
    [Abstract] [Full Text] [Related]

  • 14. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y, Cluet Y, Titeca-Beauport D, El Esper N, Ureña P, Bodeau S, Combe C, Dussol B, Fouque D, Choukroun G, Liabeuf S.
    Toxins (Basel); 2019 May 17; 11(5):. PubMed ID: 31109001
    [Abstract] [Full Text] [Related]

  • 15. Protein-Bound Uremic Toxins and Immunity.
    Rocchetti MT, Cosola C, Ranieri E, Gesualdo L.
    Methods Mol Biol; 2021 May 17; 2325():215-227. PubMed ID: 34053061
    [Abstract] [Full Text] [Related]

  • 16. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
    Deltombe O, Van Biesen W, Glorieux G, Massy Z, Dhondt A, Eloot S.
    Toxins (Basel); 2015 Sep 28; 7(10):3933-46. PubMed ID: 26426048
    [Abstract] [Full Text] [Related]

  • 17. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
    Huang WH, Hung CC, Yang CW, Huang JY.
    Ther Apher Dial; 2012 Aug 28; 16(4):361-7. PubMed ID: 22817125
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes.
    Deltombe O, Glorieux G, Marzouki S, Masereeuw R, Schneditz D, Eloot S.
    Toxins (Basel); 2019 Jul 01; 11(7):. PubMed ID: 31266243
    [Abstract] [Full Text] [Related]

  • 20. The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients.
    Wu PH, Lin YT, Chiu YW, Baldanzi G, Huang JC, Liang SS, Lee SC, Chen SC, Hsu YL, Kuo MC, Hwang SJ.
    Sci Rep; 2021 Feb 15; 11(1):3786. PubMed ID: 33589722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.